Filed: 8/4/2026ACC: 0000908834-26-000375
📋 What this filing means
ESSEX WOODLANDS MANAGEMENT, INC. filed this quarterly 13F‑HR report disclosing 5 equity positions with a total reported market value of $254.23M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
5
Positions
$254.23M
Total AUM (reported)
51.12M
Total Shares
Allocation by class
COM CL A$122.92M48.3%
COM$114.34M45.0%
COM NEW$16.97M6.7%
Portfolio Concentration
Top 3$246.99M97.1%
4–10$7.25M2.9%
Top 3 weight
97.1%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 51.12M
Sole
Full voting authority
51.12M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole5
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings5
Rows:
BIOVENTUS INC
SOLEShares13.02M
TypeSH
Market value$122.92M
48.35%
Sole
13.02M
Shared
0.00
None
0.00
MIMEDX GROUP INC
SOLEShares28.20M
TypeSH
Market value$108.55M
42.70%
Sole
28.20M
Shared
0.00
None
0.00
EYEPOINT PHARMACEUTICALS INC
SOLEShares1.08M
TypeSH
Market value$15.51M
6.10%
Sole
1.08M
Shared
0.00
None
0.00
TELA BIO INC
SOLEShares7.71M
TypeSH
Market value$5.79M
2.28%
Sole
7.71M
Shared
0.00
None
0.00
MEDICINOVA INC
SOLEShares1.11M
TypeSH
Market value$1.46M
0.57%
Sole
1.11M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
BIOVENTUS INCSOLE | COM CL A | 13.02M | SH | $122.92M 48.35% | 13.02M | 0.00 | 0.00 |
MIMEDX GROUP INCSOLE | COM | 28.20M | SH | $108.55M 42.70% | 28.20M | 0.00 | 0.00 |
EYEPOINT PHARMACEUTICALS INCSOLE | COM NEW | 1.08M | SH | $15.51M 6.10% | 1.08M | 0.00 | 0.00 |
TELA BIO INCSOLE | COM | 7.71M | SH | $5.79M 2.28% | 7.71M | 0.00 | 0.00 |
MEDICINOVA INCSOLE | COM NEW | 1.11M | SH | $1.46M 0.57% | 1.11M | 0.00 | 0.00 |